Charles River Laboratories International Inc.

Exporter
251 Ballardvale St., Wilmington, MA 01887-1096, United States
(877)274-8371, (781)222-6000, (978)658-7132 fax, http://www.criver.com

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Charles River has been operating since 1947 and was incorporated as Charles River Laboratories International Inc. in 1994. In 2000, the company completed the initial public offering of Charles River Laboratories International and its stock is traded on the New York Stock Exchange. The company is a global provider of solutions that accelerate the drug discovery and development process, including research models and associated services, and outsourced preclinical services. Charles Rivers Laboratories currently has two business segments: research models and services (RMS) and preclinical services (PCS). For 60 years, the company has provided the animal research models required in the research and development of new drugs, devices and therapies. Additionally, Charles River Laboratories offers its customers a diverse and growing portfolio of products and services to enable them to reduce costs, increase speed and enhance productivity and effectiveness in drug discovery and development. The company's customer base includes global pharmaceutical companies, biotechnology companies, government agencies, and leading hospitals and academic institutions around the world. Headquartered in Wilmington, Mass. Charles River Laboratories currently operates approximately 70 facilities in 17 countries worldwide. More

Manufacturing: Research tools and integrated support services that enable drug discovery and development, including transgenic services, infectious disease and genetic testing, contract site management and laboratory and research support services; supplier of animals for research.